Curoverse Raises $1.5M to Commercialize PGP's Software | GenomeWeb

NEW YORK (GenomeWeb News) – Curoverse has raised $1.5 million in seed money that it will use to develop commercial software products based on Arvados, an open-source computational storage platform that was developed to support Harvard's Personal Genome Project.

The funds raised in the round include investments from Hatteras Venture Partners, Point Judith Ventures, Common Angels, MassVentures, and Boston Global Ventures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.